Neuve Chapelle, France

Philippe Mondon

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 5.9

ph-index = 2

Forward Citations = 27(Granted Patents)


Location History:

  • Donneville, FR (2014 - 2016)
  • Neuve Chapelle, FR (2017 - 2023)

Company Filing History:


Years Active: 2014-2025

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Philippe Mondon: Innovator in Immunotherapy

Introduction

Philippe Mondon, based in Neuve Chapelle, France, is a notable inventor with a focus on immunotherapy. With a total of 7 patents to his name, Mondon has made significant contributions to the treatment of autoimmune and inflammatory diseases through the modification of antibody Fc fragments. His innovative approaches highlight his commitment to advancing medical science.

Latest Patents

Mondon's latest patents showcase his groundbreaking work in immunotherapy. One of his most prominent inventions involves the use of modified Fc fragments in the treatment of autoimmune and/or inflammatory diseases. This patent emphasizes the application of isolated recombinant Fc fragments that possess a modified affinity for Fc receptors, particularly an increased affinity to FcRn.

Additionally, Mondon has developed Fc mutants with altered functional activity, which includes a polypeptide featuring a mutated Fc region. This polypeptide exhibits functional capabilities, mediated by the Fc region, that differ from those of a parent polypeptide. This patent outlines the combination of mutations necessary to achieve the desired modifications, paving the way for new therapeutic avenues.

Career Highlights

Philippe Mondon's professional experience includes key roles at renowned organizations, such as the Laboratoire Français du Fractionnement et des Biotechnologies. His tenure at this institution reflects his dedication to biotechnological advancements and his pursuit of innovative healthcare solutions.

Collaborations

Throughout his career, Mondon has collaborated with distinguished colleagues, including Abdelhakim Kharrat and Khalil Bouayadi. These partnerships have enhanced his research capabilities and contributed to the successful development of his patents, fostering a collaborative environment necessary for innovation.

Conclusion

Philippe Mondon stands out as an influential inventor in the realm of immunotherapy. His commitment to improving treatments through innovative biotechnological solutions is evident in his patents and collaborations. As the field of immunotherapy continues to evolve, Mondon’s contributions will undoubtedly play a crucial role in shaping future advancements in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…